Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma.

Arch Immunol Ther Exp (Warsz)

Department of Dermatology, Medical Academy, Warsaw, Poland.

Published: January 1996

Three patients with diffuse variety of systemic scleroderma were treated with 2-chloro-2'-deoxyadenosine. In two of them a moderate improvement of skin involvement was observed. No significant effects of the drug on the immunological parameters have been found.

Download full-text PDF

Source

Publication Analysis

Top Keywords

systemic scleroderma
8
systemic administration
4
administration 2-chloro-2'-deoxyadenosine
4
2-chloro-2'-deoxyadenosine 2-cda
4
2-cda patients
4
patients systemic
4
scleroderma three
4
three patients
4
patients diffuse
4
diffuse variety
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!